Apeiron Data Systems Announces Major Food & Drug Administration (FDA) Storage Contract
Apeiron to provide ultra high density and performance systems for electronic discovery environments
Apeiron’s VP of N. America Sales, Jim Steed says: “Aside from all of the 'standard' storage and compute capabilities, Apeiron provides the FDA with significant consolidation while delivering the high performance ingest and query capabilities these environments demand. The current and future NVMe drive capabilities are were critical to this decision as well. Because Apeiron can address any NVMe SSD, from any supplier the FDA can now choose the proper drive for the particular workload. This translates to consolidation of both compute and storage, which of course means a lower Total Cost of Ownership.”
Apeiron’s ADS1000 provides a native NVMe over Ethernet storage network. Storage management is moved to the application servers instead of an embedded/proprietary controller. This results in the elimination of the #1 bottleneck to server and storage performance-the storage controller. With the ability to provide 184 TB per 2U enclosure (going to 360 TB in September 2017), the ADS1000 simply cannot be matched in the categories of both density and performance.
James L. Steed
Apeiron Sales
18007010243
email us here
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.